122 related articles for article (PubMed ID: 7629283)
1. Multifactorial audit of invasive cervical cancer: key lessons for the National Screening Programme.
Slater DN
J Clin Pathol; 1995 May; 48(5):405-7. PubMed ID: 7629283
[TBL] [Abstract][Full Text] [Related]
2. Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme.
Slater DN; Milner PC; Radley H
J Clin Pathol; 1994 Jan; 47(1):27-8. PubMed ID: 8132804
[TBL] [Abstract][Full Text] [Related]
3. An audit of cervical cancer deaths in Nottingham.
Wilson SH; Johnson J
Cytopathology; 1992; 3(2):79-83. PubMed ID: 1617163
[TBL] [Abstract][Full Text] [Related]
4. An audit of a cervical smear screening programme.
Moodie PJ; Kljakovic M; McLeod DK
N Z Med J; 1989 Jul; 102(872):374-6. PubMed ID: 2797554
[TBL] [Abstract][Full Text] [Related]
5. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
7. An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study.
Blanks RG; Moss SM; Coleman DA; Swerdlow AJ
BJOG; 2007 Nov; 114(11):1408-13. PubMed ID: 17803716
[TBL] [Abstract][Full Text] [Related]
8. Negative cytology preceding cervical cancer: causes and prevention.
Robertson JH; Woodend B
J Clin Pathol; 1993 Aug; 46(8):700-2. PubMed ID: 8408692
[TBL] [Abstract][Full Text] [Related]
9. A smear on audit. Implications of the Leicester cervical smear audit.
Symonds P; Naftalin N; Shaw P
BJOG; 2003 Jul; 110(7):646-8. PubMed ID: 12842054
[No Abstract] [Full Text] [Related]
10. The characteristics of false negative cervical smears--implications for the UK cervical cancer screening programme.
Baker RW; O'Sullivan JP; Hanley J; Coleman DV
J Clin Pathol; 1999 May; 52(5):358-62. PubMed ID: 10560356
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening in England.
Patnick J
Eur J Cancer; 2000 Nov; 36(17):2205-8. PubMed ID: 11072205
[TBL] [Abstract][Full Text] [Related]
12. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
13. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
Lynge E; Poll P
IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
15. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
[TBL] [Abstract][Full Text] [Related]
16. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
17. The agreement between self-reported cervical smear abnormalities and screening programme records.
Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
[TBL] [Abstract][Full Text] [Related]
18. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
19. Setting standards for cervical screening fail-safe mechanisms: a target based on an audit of cytopathology laboratory records.
Roberts E; Cook GA; Walsworth-Bell JP; Barrow S
J Med Screen; 1995; 2(2):102-4. PubMed ID: 7497153
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
